Premium
Characterization of Fibrin Degradation Products in Patients on Ancrod Therapy: Comparison with Fibrinogen Derivatives Produced by Plasmin
Author(s) -
Prentice C. R. M.,
Edgar W.,
McNicol G. P.
Publication year - 1974
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1974.tb06776.x
Subject(s) - plasmin , fibrinogen , fibrin , chemistry , proteolysis , immunodiffusion , biochemistry , medicine , enzyme , immunology , antibody
S ummary . The fibrin digestion products which appear in serum of patients having treatment with ancrod have been compared with derivatives of human fibrinogen produced by plasmin by means of immunoelectrophoresis, immunodiffusion and gel filtration techniques. In ancrod‐treated patients the large molecular weight derivatives X and Y, as well as fragments D and E were seen 4 hr after the start of therapy. By 24 hr the main serum component was fragment D with low concentrations of large molecular weight derivatives still present, but fragment E had been cleared from the circulation. The identity of these fragments to the known products of fibrinogen proteolysis by plasmin has been confirmed. It is suggested that the initial degradation of fibrin micro‐clots produced in the circulation during ancrod infusion is mediated by the fibrinolytic enzyme system.